Literature DB >> 4072675

Portal vein or hepatic vein? A curious aberrant vasculature in the liver with idiopathic portal hypertension.

K Fukuda, M Kage, M Arakawa, T Nakashima.   

Abstract

The existence of aberrant vasculatures has been described as one of the characteristic findings in the liver with idiopathic portal hypertension (IPH). In this paper, the morphological features and the genesis of aberrant vasculatures were studied on the basis of autopsy and biopsy materials of IPH and animal experiments. Aberrant vasculatures in IPH livers are characterized as thin-walled vessels located mainly adjacent to the portal tracts and at times in the hepatic lobules. Although some of them are morphologically very similar to hepatic vein branches, they are portal in nature. These aberrant vessels develop in order to compensate for portal circulatory insufficiency due to obliteration of portal vein branches, and play an important role in maintaining an adequate blood supply to the parenchyma. It is predicted that decrease of these intrahepatic collateral vessels is responsible for or related to parenchymal atrophy and deterioration of liver function in the advanced stage of this disease. We regard these vasculatures as characteristic of the intrahepatic portal venous obstruction, particularly with portal hypertension accompanied by increased portal blood flow.

Entities:  

Mesh:

Year:  1985        PMID: 4072675

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  6 in total

1.  Microvasculature in the small portal tracts in idiopathic portal hypertension. A morphological comparison with other hepatic diseases.

Authors:  T Terada; M Hoso; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 2.  Noncirrhotic portal hypertension.

Authors:  Harshal Rajekar; Rakesh K Vasishta; Yogesh K Chawla; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

3.  Pathology of idiopathic non-cirrhotic portal hypertension.

Authors:  Masayoshi Kage
Journal:  Hepatol Int       Date:  2017-09-13       Impact factor: 6.047

Review 4.  Pathology of idiopathic non-cirrhotic portal hypertension.

Authors:  Maria Guido; Samantha Sarcognato; Diana Sacchi; Guido Colloredo
Journal:  Virchows Arch       Date:  2018-04-12       Impact factor: 4.064

5.  Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment.

Authors:  Shiv Kumar Sarin; Ashish Kumar; Yogesh Kumar Chawla; Sanjay Saran Baijal; Radha Krishna Dhiman; Wasim Jafri; Laurentius A Lesmana; Debendranath Guha Mazumder; Masao Omata; Huma Qureshi; Rizvi Moattar Raza; Peush Sahni; Puja Sakhuja; Mohammad Salih; Amal Santra; Barjesh Chander Sharma; Praveen Sharma; Gamal Shiha; Jose Sollano
Journal:  Hepatol Int       Date:  2007-09-11       Impact factor: 6.047

6.  Pulmonary hypertension associated with non-cirrhotic portal hypertension in systemic lupus erythematosus.

Authors:  D Woolf; M D Voigt; K Jaskiewicz; A A Kalla
Journal:  Postgrad Med J       Date:  1994-01       Impact factor: 2.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.